Published in Biotech Business Week, January 5th, 2009
"The AMIA has defined translational bioinformatics as ''... the development of storage, analytic, and interpretive methods to optimize the transformation of increasingly voluminous biomedical data into proactive, predictive, preventative, and participatory health.'' In this perspective, I will list eight reasons why this is an excellent time to be Studying translational bioinformatics, including the significant increase in funding opportunities...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.